Premium
A Phototheranostic Strategy to Continuously Deliver Singlet Oxygen in the Dark and Hypoxic Tumor Microenvironment
Author(s) -
Zou Jianhua,
Zhu Jianwei,
Yang Zhen,
Li Ling,
Fan Wenpei,
He Liangcan,
Tang Wei,
Deng Liming,
Mu Jing,
Ma Yuanyuan,
Cheng Yaya,
Huang Wei,
Dong Xiaochen,
Chen Xiaoyuan
Publication year - 2020
Publication title -
angewandte chemie
Language(s) - English
Resource type - Journals
eISSN - 1521-3757
pISSN - 0044-8249
DOI - 10.1002/ange.201914384
Subject(s) - singlet oxygen , photodynamic therapy , chemistry , photochemistry , tetraphenylethylene , tumor microenvironment , irradiation , oxygen , photosensitizer , biophysics , hypoxia (environmental) , peg ratio , fluorescence , cancer research , tumor cells , aggregation induced emission , organic chemistry , biology , physics , quantum mechanics , finance , nuclear physics , economics
Continuous irradiation during photodynamic therapy (PDT) inevitably induces tumor hypoxia, thereby weakening the PDT effect. In PDT‐induced hypoxia, providing singlet oxygen from stored chemical energy may enhance the cell‐killing effect and boost the therapeutic effect. Herein, we present a phototheranostic (DPPTPE@PEG‐Py NPs) prepared by using a 2‐pyridone‐based diblock polymer (PEG‐Py) to encapsulate a semiconducting, heavy‐atom‐free pyrrolopyrrolidone‐tetraphenylethylene (DPPTPE) with high singlet‐oxygen‐generation ability both in dichloromethane and water. The PEG‐Py can trap the 1 O 2 generated from DPPTPE under laser irradiation and form a stable intermediate of endoperoxide, which can then release 1 O 2 in the dark, hypoxic tumor microenvironment. Furthermore, fluorescence‐imaging‐guided phototherapy demonstrates that this phototheranostic could completely inhibit tumor growth with the help of laser irradiation.